<p>One year BC-free survival curve for live-transplant patients according to the Kaplan–Meier method. BC-free survival probability of Patients received intraoperative cryoprecipitate transfusions(red line) was statistically significant lower when compared to the group that received no cryoprecipitate (blue line)(<i>P</i><0.001).</p
<p>Hyperuricemic group survival curve was significantly (P = 0.007) lower than that of normouricemic...
<p>Longitudinal survivals of patient survival (<b>A</b>), death-censored graft survival (<b>B</b>) a...
<p>Unadjusted Kaplan—Meier survival curves of risk of mortality after liver transplantation in the p...
<p>(A) 1-year survival (78.7%) and (B) 5-year survival (74%) of all 282 patients transplanted betwee...
<p>The blue curve corresponds to the Kaplan-Meier survival curve for the entire population used to l...
<p>Kaplan-Meier estimates cumulative survival between patients with or without VEBs>1000/24h. Black ...
<p>(A) Recipient survival curve. BMMSCs improved the recipient survival rate significantly (p = 0.01...
<p>Estimated Kaplan-Meier survival curves for transplant and non-transplant cohorts, derived from a ...
<p>Kaplan-Meier survival curves for different periods in post- and pre- transplantation.</p
<p>Non-HIV, non-transplant patients had the lowest survival, but the difference across groups did no...
<p>Patient survival (A) and overall graft survival (B) for weekday and weekend kidney transplantatio...
<p>No significant difference can be acquired on patient survival rate between these groups.</p
<p>The black solid line shows the observed cumulative mortality and dotted lines show the 95% confid...
Graft survival censored for death in the group with CaOx deposition (N = 26) and the group without C...
<p>(A) Overall survival in patients with non-advanced disease at the time of BMT. (B) Overall surviv...
<p>Hyperuricemic group survival curve was significantly (P = 0.007) lower than that of normouricemic...
<p>Longitudinal survivals of patient survival (<b>A</b>), death-censored graft survival (<b>B</b>) a...
<p>Unadjusted Kaplan—Meier survival curves of risk of mortality after liver transplantation in the p...
<p>(A) 1-year survival (78.7%) and (B) 5-year survival (74%) of all 282 patients transplanted betwee...
<p>The blue curve corresponds to the Kaplan-Meier survival curve for the entire population used to l...
<p>Kaplan-Meier estimates cumulative survival between patients with or without VEBs>1000/24h. Black ...
<p>(A) Recipient survival curve. BMMSCs improved the recipient survival rate significantly (p = 0.01...
<p>Estimated Kaplan-Meier survival curves for transplant and non-transplant cohorts, derived from a ...
<p>Kaplan-Meier survival curves for different periods in post- and pre- transplantation.</p
<p>Non-HIV, non-transplant patients had the lowest survival, but the difference across groups did no...
<p>Patient survival (A) and overall graft survival (B) for weekday and weekend kidney transplantatio...
<p>No significant difference can be acquired on patient survival rate between these groups.</p
<p>The black solid line shows the observed cumulative mortality and dotted lines show the 95% confid...
Graft survival censored for death in the group with CaOx deposition (N = 26) and the group without C...
<p>(A) Overall survival in patients with non-advanced disease at the time of BMT. (B) Overall surviv...
<p>Hyperuricemic group survival curve was significantly (P = 0.007) lower than that of normouricemic...
<p>Longitudinal survivals of patient survival (<b>A</b>), death-censored graft survival (<b>B</b>) a...
<p>Unadjusted Kaplan—Meier survival curves of risk of mortality after liver transplantation in the p...